Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
F7 encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. Additionally we are shipping Factor VII Antibodies (191) and Factor VII Proteins (31) and many more products for this protein.
Showing 10 out of 49 products:
Davie, Fujikawa, Kurachi, Kisiel: The role of serine proteases in the blood coagulation cascade. in Advances in enzymology and related areas of molecular biology 1979
Show all 5 references for ABIN612644
Mouse (Murine) Factor VII ELISA Kit for Sandwich ELISA - ABIN425161
Wang, Braun, Zhang, Norström, Thorlacius: Monocytes regulate systemic coagulation and inflammation in abdominal sepsis. in American journal of physiology. Heart and circulatory physiology 2015
Human Factor VII ELISA Kit for Sandwich ELISA - ABIN417285
Teligui, Dalmayrac, Corbeau, Bouquet, Godon, Denommé, Binuani, Verron, Boer, Baufreton: Ex vivo simulation of cardiopulmonary bypass with human blood for hemocompatibility testing. in Perfusion 2016
Hepsin (show HPN ELISA Kits) plays a physiologically important role in factor VII (show TH ELISA Kits) activation and hemostasis in zebrafish.
study reports the full-length cDNA sequences of rhesus monkey FVII; deduced protein sequence of FVII indicates the functional domains; comparison of three-dimensional protein structure with human shows high conservation between them
FVIIa binding to EPCR (show PROCR ELISA Kits) leads to a barrier protective effect in vivo
FVIIa binding to EPCR (show PROCR ELISA Kits) on the endothelium facilitates the transport of FVIIa from circulation to extravascular tissues where TF resides
Murine FVIIa binds poorly to murine EPCR (show PROCR ELISA Kits).
Conclude that the fVII-targeted verteporfin photodynamic therapy that we report here is a novel and effective therapeutic with improved selectivity for the treatment of breast cancer.
The participation of Egr-1 (show EGR1 ELISA Kits) in FVIIa-mediated regulation of keratinocyte function was confirmed by use of Egr-1 (show EGR1 ELISA Kits)-deficient mice, wherein a significant delay in skin wound healing after injury was observed, relative to WT mice.
Recombinant FVIIa readily associates with the vascular endothelium and subsequently enters into extravascular spaces where it is likely to bind to tissue factor (show F3 ELISA Kits) and is retained for extended time periods.
Gene targeting of tissue factor (show F3 ELISA Kits), factor X, and factor VII (show TH ELISA Kits) in mice: their involvement in embryonic development
true circadian rhythms for FVII were found
Data suggest that long-term expression of murine activated factor VII (show TH ELISA Kits) is safe, but elevated levels cause premature mortality.
tissue factor (show F3 ELISA Kits)/Factor VIIa/PAR2 (show F2RL1 ELISA Kits) signaling mediates neutrophil activation and fetal death in antiphospholipid syndrome and that statins may be a good treatment for women with aPL (show FASL ELISA Kits)-induced pregnancy complications.
Large deletions play a minor but essential role in the mutational spectrum of the F7 and F10 (show F10 ELISA Kits) genes. Copy number analyses (e. g. MLPA) should be considered if sequencing cannot clarify the underlying reason of an observed coagulopathy. Of note, in cases of combined FVII/FX deficiency, a deletion of the two contiguous genes might be part of a larger chromosomal rearrangement.
Structure-Function Relationship of the Interaction between Tissue Factor (show F3 ELISA Kits) and Factor VIIa.
Data suggest that allosteric regulation of FVIIa activity by tissue factor/thromboplastin (show F3 ELISA Kits) binding appear to involve direct interaction with FVIIa active site, stabilizing segment 215-217, activating loop 3, and leading to enhanced FVIIa activity.
The aim of the study was to evaluate the molecular basis behind low levels of FVII activity (FVII:C) levels in a cohort of Brazilian patients.
The story of FVII well summarizes the efforts of both theoretical and clinical approaches in the characterization of a coagulation disorder, that is, among the rare bleeding conditions, most frequently encountered in clinical practice.
Identified are the FVII gene mutations in the Chinese Han population of four unrelated FVII-deficient patients, and the effect of these mutations on the function of FVII molecule level has also been elucidated.
Molecular dynamics simulation of tissue factor (show F3 ELISA Kits) activation of factor VIIa.
results suggest that these TF residues interact with the GLA domain (show F9 ELISA Kits) of FX in a Mg(2 (show MUC7 ELISA Kits)+)-dependent manner (although effects of Mg(2 (show MUC7 ELISA Kits)+) on the FVIIa GLA domain (show F9 ELISA Kits) cannot be ruled out).
Describe inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI (show TFPI ELISA Kits) and TFPI (show TFPI ELISA Kits) constructs.
Letter: large volume of distribution of rFVIIa explains the persistence of some clotting potential when FVII:C is no longer detectable in plasma of patients with inherited FVII deficiency.
This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
coagulation factor VII
, clotting factor
, serum prothrombin conversion accelerator
, FVII coagulation protein
, eptacog alfa